Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

common-default.jpeg

Terms / Notices

Cookies

Privacy Policy

Reporting Hotline

Attorney Advertising

Alumni

  Linkedin

MoFo LinkedIN

  Facebook

MoFo Facebook

YouTube

MoFo Youtube

Morrison Foerster - Footer

Morrison Foerster Recognized in The Legal 500 China 2026

You have not solved the recaptcha challenge yet or session expired, try again.

Email Disclaimer

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Community

Offices

Careers

Stay Connected

Morrison Foerster has received 19 practice area rankings and 76 individual recognitions across its offices in Hong Kong and...

<h3>Sorry, we weren’t able to find the terms you entered.</h3>Please try a different term or keyword.

People

Capabilities

Resources

Not Found Cards

About Morrison Foerster

people-default-header-desktop.jpg

people-default-header-mobile.jpg

Default Meta Data

Morrison Foerster has received 19 practice area rankings and 76 individual recognitions across its offices in Hong Kong and Shanghai in The Legal 500 China 2026 guide.The firm received three Tier 1 practice area recognitions, including the following:<ul><li>Data Protection: Foreign Firms</li><li>Private Equity: Foreign Firms</li><li>TMT: Foreign Firms</li></ul>Morrison Foerster saw improved rankings in this year’s edition for China: Regulatory/Compliance: Foreign Firms and Hong Kong: Dispute Resolution: Litigation, both reflecting MoFo’s continued investment and development in China and Hong Kong.Of the individual recognitions received in the 2026 edition, MoFo lawyers received seven Leading Partner rankings:<ul><li>Paul McKenzie – China: Data Protection: Foreign Firms; China: Corporate and M&A: Foreign Firms</li><li>Chuan Sun – China: Data Protection: Foreign Firms; China: TMT: Foreign Firms</li><li>Matthew Lau – Hong Kong: Domestic and International Corporate Tax</li><li>Marcia Ellis – China: Private Equity: Foreign Firms; Hong Kong: Private Equity</li></ul>Two MoFo lawyers were also recognized as Next Generation Partners:<ul><li>Derik Rao – China: Regulatory/Compliance: Foreign Firms</li><li>Xiaoxi Lin – Hong Kong: Private Equity</li></ul>Additionally, four MoFo lawyers received Leading Associate rankings:<ul><li>Tingting Gao – China: Data Protection: Foreign Firms</li><li> Sarah Wang – China: Life Sciences and Healthcare: Foreign Firms</li><li>Siyu Gao – China: Private equity: foreign firms</li><li>Gigi Yuen – Hong Kong: TMT</li></ul>The firm also received one Hall of Fame designation. Gordon Milner was named to the Hall of Fame for Hong Kong: TMT.For more than 40 years, Morrison Foerster has been on the ground advising clients on their most important China-related matters. We were among the first U.S. law firms to establish an office in China’s major business centers. We have about 50 attorneys qualified in the U.S., Hong Kong, PRC, and England & Wales, who work closely with attorneys throughout the firm to deliver calibrated and sound advice to clients. We counsel a wide variety of clients in China on their most high-profile investments, as well as on finance and regulatory matters. Our clients include many of the world’s largest multinationals, private equity/real estate/venture/credit fund managers, institutional investors, and the most substantial and active institutional companies in the region. We provide legal advice to companies across a broad range of sectors, including technology, life sciences, data center, financial institutions, AI, fintech, digital media, food & agriculture, and semiconductor.To view the complete list of Morrison Foerster’s rankings in the 2026 edition of The Legal 500 China, please visit the publication’s <a href="https://www.legal500.com/c/china/" target="_blank">website</a>.

Morrison Foerster Recognized in The Legal 500 China 2026

Sign Up

Paul has more than 30 years’ experience advising leading international companies on complex transactional and other business law matters in China and elsewhere in Asia.He advises Fortune 100 and other global companies pursuing M&A, joint venture, and other corporate transactions, bringing to his work a deep understanding of the regulatory environment in China and a sensitivity to cultural issues in Asia. Paul also helps clients navigate China’s complex and changing regulatory environment, advising on a broad range of issues such as data privacy and security, industry permitting, and anti-corruption compliance. Paul is a member of the firm’s market-leading global data, cyber and privacy group and a recognized expert on China’s emerging data regulatory regime. He works across a broad range of industries, including information technology, real estate, chemicals and energy, and natural resources.Paul is a fluent Mandarin speaker and has written widely on issues related to Chinese law.He serves on the board of directors of The Morrison & Foerster Foundation, the firm’s charitable foundation.

麦保罗（Paul McKenzie）律师在代表领先的国际公司处理中国和其他亚洲地区的复杂交易和其他商业法律事宜方面拥有超过30年的经验。麦保罗律师代表财富100强企业和其他全球公司处理并购、合资和其他公司交易事宜，同时将他对中国监管环境的深入了解，以及对亚洲文化问题的敏锐运用于其中。他还帮助客户应对中国复杂且不断变化的监管环境，并就各类问题（例如数据隐私与网络安全，行业许可和反腐败合规）提供咨询。麦保罗律师还是本所市场领先的全球隐私和数据安全业务组的成员之一，也是中国新兴数据监管制度领域公认的业内专家。麦保罗律师的业务涉及广泛的行业，包括信息技术，房地产，化学品，能源和自然资源。他精通汉语，并针对中国法律的相关问题广泛撰文。麦保罗律师是本所的慈善基金 “美富基金会”的董事会成员。

Paul McKenzie

Partner

Chuan Sun is Managing Partner of the Shanghai and Hong Kong offices.Chuan focuses his practice on cross-border M&A transactions; sophisticated technology, media, and telecom (TMT) transactions; and complex IP/commercial matters across Greater China.With more than 20 years of experience in both Asia and the U.S., Chuan regularly advises multinational corporations, state-owned enterprises, private companies, and PE/VC firms in complex cross-border M&A transactions, joint ventures, strategic alliances, and business separation transactions.Chuan has extensive experience in complex corporate-commercial and technology transactions across the Fintech, e-commerce, and broader TMT sectors. His work covers payment technology, eKYC, credit technology, blockchain, e-platform arrangements, R&D, co-development, technology collaborations, and IP licensing. He also advises on strategic outsourcing, manufacturing, distribution, supply, and franchising arrangements across various industries.Chuan regularly counsels clients on cutting-edge technology and IP regulatory matters, including Fintech, data privacy, cybersecurity, data localization, cross-border data transfers, cloud computing, telecommunications, telematics, and third-party payment services.Prior to joining MoFo, he worked in the Hong Kong office of a Magic Circle firm and the Chicago office of another leading international firm.Chuan co-authored the Hong Kong & mainland China chapters of Getting the Deal Through – Telecoms and Media, 2014, 2015 & 2016; the Hong Kong & mainland China chapters of Getting the Deal Through: Market Intelligence – Telecoms and Media, 2015; and the Hong Kong chapter of Sourcing World 2nd Edition 2015.Chuan is fluent in Mandarin and English.“Chuan Sun has a wealth of knowledge on his clients’ existing products and services offerings and a good understanding of what terms they are or are not willing to accept. This helps tremendously with contract negotiations.”“Chuan Sun has extensive experience in the technology space. Many other competitor firms in the technology space are not really pure IT lawyers, as they are more focus on privacy and trade marks or other related fields, as opposed to technology contracts such as SAP or Microsoft software license agreements. A normal general commercial lawyer would not be able to identify the same issues or raise the right questions, as they are not equipped with the technology know-how of the products and services, their benefits, and general industry standard terms and trending patterns in the market.” Legal 500 Asia Pacific 2020<h4>Representative Experience:</h4><ul><li>CPE, a Chinese alternative investment firm, in connection with its US$350 million joint venture with Restaurant Brands International (RBI), one of the world's largest multinational fast food holding company, to operate Burger King in China which has around 1,250 restaurants in total. This transaction is one of the most significant private equity-led transactions in China’s consumer sector in 2025.</li><li>OcuMension Therapeutics (HKSE: 01477), a Hong Kong Stock Exchange listed ophthalmic pharmaceutical platform in China in its acquisition of substantial assets valued at HK$1.28 billion (approximately US$165 million) from Alcon Inc., a global leader in eye care. The transaction involves asset purchase, global license, transition services and manufacture and supply arrangement and constitutes a very substantial transaction of OcuMension.</li><li>Ascendent Capital Partners in its US$1.66 billion privatization of Hollysys Automation Technologies Ltd. (NASDAQ: HOLI), a leading international automation control system solutions provider. This is a rare transaction where a PE fund successfully acquires a US-listed Chinese company without forming a consortium with controlling shareholder or management. It is also the first and only U.S. take-private of a BVI-incorporated company involving a dissenter process. </li></ul><ul><li>Leading Global, China-Headquartered Fintech Company. Advise the company in connection with its first provision of blockchain and Real World Asset solutions in the fintech industry to a leading Chinese securities company for the latter’s first launch of structured product tokens, enabling secure, transparent, tamper-proof transactions for fixed-income and principal-protected tokenized products linked to US equity ETFs.</li><li>Leading Global, China-Headquartered Fintech Company. Advise the company in connection with the international expansion of its various business operations that are based on cutting-edge technologies, including blockchain and crypto, into multiple jurisdictions. </li></ul>

孙川是美富上海办公室和香港办公室的管理合伙人。孙川律师的执业领域集中在大中华区的跨境并购交易，复杂的技术、媒体和电信(TMT)交易以及复杂的知识产权/商务事宜。孙律师在亚洲和美国有20多年工作经验，他经常代理跨国公司、国有企业、私人企业和私募股权/风险投资机构处理复杂的跨境并购交易、合资、战略联盟和业务拆分等交易。孙律师在战略性的公司商务和技术交易方面也拥有极为丰富的经验，包括外包、制造、分销、供应与特许经营安排，以及跨行业知识产权许可安排等。他在TMT和知识产权监管方面的经验包括电信、电子商务、互联网、网络安全、数据隐私、云计算以及车联网。在加入美富前，孙律师在一家 “魔法圈”律所(Magic Circle)的香港办事处和另一家领先的国际律所的芝加哥办事处工作。孙律师与他人合著了2014，2015和2016版《让交易推进下去––电信与媒体》(Getting the Deal Through – Telecoms and Media)中的香港和中国大陆章节，2015年版《让交易推进下去：市场情报––电信与媒体》(Getting the Deal Through: Market Intelligence – Telecoms and Media)中的香港和中国大陆章节，以及2015年《采购世界》第二版(Sourcing World 2nd Edition)的香港章节。2018年《亚太法律500强》指出“孙川律师十分高效、负责和实际。他非常擅长处理IT协议，包括软件许可和IT采购合同的相关事宜。他也十分善于处理跨境TMT交易。”孙律师精通普通话和英语。<h4>具有代表性的交易 </h4><ul><li>代表中国另类投资公司CPE源峰 就其与世界上最大的餐饮公司之一餐饮品牌国际集团（Restaurant Brands International，简称 RBI）成立价值3.5亿美元的合资企业。该合资企业将负责汉堡王在中国的运营，目前在全国拥有约 1,250 家餐厅。本次交易是 2025 年中国消费行业中由私募股权基金主导的最具代表性交易之一。</li><li>代表香港上市的中国眼科制药平台欧康维视生物医药(HKSE: 01477)处理其收购全球眼科护理领域的领导者爱尔康公司价值 12.8 亿港元（约 1.65 亿美元）重大资产的事宜。交易涉及资产收购，以及全球许可、过渡期服务、生产和供应安排等，是欧康维视的一项非常重大交易。</li><li>代表上达资本处理其以16.6亿美元对和利时自动化技术有限公司（纳斯达克证券交易所股票代码：HOLI）进行私有化事宜。和利时是一家领先的国际自动化控制系统解决方案提供商。这是一宗罕见的交易。在这宗交易中，私募股权基金在未与控股股东或管理层组建财团的情况下，就成功收购了在美国上市的中国公司。这也是首宗且唯一一宗涉及异议股东程序的，在英属维尔京群岛注册成立的公司的美国上市公司私有化交易。</li><li>代表一家总部位于中国的全球领先金融科技公司首次为金融科技行业提供区块链及现实世界资产（RWA）解决方案，协助一家中国头部证券公司首次发行结构化产品代币。该方案为挂钩美国股票ETF的固定收益及保本型代币化产品提供了安全、透明且防篡改的交易支持‌。</li><li>代表一家总部位于中国的全球领先金融科技公司处理基于区块链和加密货币等尖端技术开展的各项业务在多个司法管辖区进行国际扩张的事宜。</li></ul>

Chuan Sun

Managing Partner, Shanghai and Hong Kong

Matthew’s practice focuses on the structuring of cross‑border M&A transactions and corporate reorganizations, particularly involving the United States, China, Japan, and the rest of the Asia‑Pacific region. He specializes in guiding clients through the intricacies of cross‑border transaction structures and intellectual property management from a tax perspective.Matthew has deep experience advising fund sponsors and institutional investors on tax issues relating to the formation of, and investments in, private equity funds, venture capital funds, real estate funds, and other alternative investment products. He has particular expertise in the U.S. taxation of government‑linked investors such as sovereign wealth funds and central banks.Matthew has represented multinational corporations and funds in transactions across more than 30 jurisdictions covering a wide range of industries, including technology, telecommunications, healthcare, real estate, consumer, media, and energy.Matthew is a Registered Foreign Lawyer with the Law Society of Hong Kong.While at Columbia Law School, Matthew was a three‑year Harlan Fiske Stone Scholar.

刘恩安（Matthew Lau）律师的业务侧重于跨境并购交易和企业重组的结构设计，特别是涉及美国、中国、日本和亚太地区其他国家的交易。他擅长从税务的角度协助客户处理复杂的跨境交易结构和知识产权管理。刘律师在为基金发起人和机构投资者就私募股权基金、风险投资基金、房地产基金和其他另类投资产品的成立和投资相关的税务问题提供法律咨询方面拥有丰富的经验。他尤其擅长处理美国对政府相关投资者（如主权财富基金和中央银行）的征税事宜。刘律师曾代表多家跨国公司和基金在30多个司法管辖区处理交易，涵盖科技、电信、医疗保健、房地产、消费品、媒体和能源等多个行业。刘律师是香港律师会注册外地律师。在美国哥伦比亚大学法学院就读期间，刘律师连续三年获得哈伦•菲斯克•斯通（Harlan Fiske Stone）奖学金。

Matthew Lau

Marcia Ellis is a Senior Counsel in our New York office and a Partner in our Hong Kong office. Marcia’s practice focuses on private equity transactions and complex mergers and acquisitions involving companies and other assets located in Asia. Having practiced in Asia for more than a quarter of a century, Marcia is one of the most experienced M&A lawyers active in the Asian market. In the past three years, she has advised clients on deals with a total aggregate value well in excess of US$249.8 billion.​Marcia regularly advises leading investors on M&A transactions, including SoftBank Vision Fund, Alibaba, GLP, Bain Capital, BlackRock, Farallon Capital, Ascendent Capital Partners, Silver Crest Acquisition Corp., PAG, Hillhouse, Hony Capital and Celadon Partners. In addition, she is experienced in representing U.S., UK and Asia based institutional investors in the acquisition, financing and disposition of real estate in China, Hong Kong and elsewhere in Asia, including numerous logistics and internet data center projects, and investment in and acquisition of real estate developers.From 2008 through 2011, she was the Chief Legal Officer for Asia of D. E. Shaw, where she assisted various group entities in making, restructuring, and exiting investments in various countries in Asia, including a number of significant and highly structured investments in China and India.Clients consider Marcia as a "super skilled technical lawyer" who offers "incredible problem-solving skills on all aspects of matters, both legal and commercial". A client said that "Finding a lawyer whose judgement you trust and who knows how far they can push the boundaries is not easy, and Marcia is the best lawyer I've worked with."Marcia is a member of our global board of directors and a member of our global Environmental, Social and Governance (ESG) Steering Committee. She served as a Global Co-Chair of the firm's Private Equity Practice. In 2022, she spearheaded the launch of MoFo’s annual survey of the ESG and DEI policies and practices of Asia-headquartered PE firms. She has also been named to Law360’s 2022 and 2023 Private Equity Editorial Board and elected as the Co-Chair of AmCham Hong Kong’s Women of Influence Committee. Marcia has been recognized as one of the Women of Influence in Private Markets: Private Equity by Private Equity International in 2024.

Marcia Ellis（艾琳）律师的执业重点是涉及亚洲境内公司和其它资产的私募股权交易和复杂并购。Ellis律师在亚洲执业超过二十五年，是活跃在亚洲市场经验最丰富的并购律师之一。在过去三年间，她为客户完成的交易的合计价值超过2498亿美元。Ellis律师经常为大型投资者提供并购交易法律咨询，这些投资者包括软银愿景基金、阿里巴巴、普洛斯、Bain Capital、贝莱德、Farallon Capital、上达资本、Silver Crest特殊目的收购公司、PAG、高瓴资本、弘毅投资以及Celadon Partners。此外，在代表美国、英国、亚洲机构投资人方面她也富有经验；她代表客户处理收购、融资、处置中国、香港及亚洲其它地区的房地产，其中包括许多物流和互联网数据中心项目，也处理对房地产开发商的投资与收购。从2008至2011年，Ellis律师是德劭集团亚洲区的首席法务官。在德劭集团，她协助各集团实体处理在亚洲多个国家进行的投资、投资重组及投资退出事宜，包括在中国和印度进行的多个重要及高度结构化的投资。客户评价Ellis律师是一位"技巧高超的律师"，她拥有 "极其出色的解决问题的能力，包括法律问题和商业问题 "。一位客户称："找到一位拥有令人信任的判断力，并能尽力突破极限的律师并不容易，而她是我合作过的最好的律师"。Ellis律师是美富律师事务所的全球董事会成员，兼本所全球环境、社会与治理(ESG)指导委员会委员之一。她曾任本所的全球私募股权业务联席主席。在2022年，她率先发起了美富对总部位于亚洲的私募股权公司的环境、社会与治理以及可持续性的政策与实践的年度调查。她还当选《法律360》(Law 360)2022年度和2023年度私募股权业务编辑委员会成员，以及香港美国商会最具影响力女性(WOI)指导委员会联席主席。Ellis律师还荣获Private Equity International评为2024年“私募股权领域：私募市场最具影响力女性”之一。

Marcia Ellis

Senior Counsel (New York) | Partner (Hong Kong)

饶宇律师的主要执业领域是合规、监管、制裁、出口管制和白领犯罪事宜，以及与《反海外腐败法》（FCPA）和其他反贿赂法相关的调查事宜。饶律师曾为金融、医疗保健、科技、电讯、加密货币等各行业的跨国公司提供法律意见，也曾代表美国、中国、日本及欧洲的企业处理各类FCPA及其他内部调查事宜，其中涉及商业贿赂、欺诈、数据隐私、挪用公款和违反信托义务的事宜。饶律师在代表跨国医药公司和医疗器械公司开展敏感的调查和设计系统性补救方案方面拥有丰富的经验。饶律师曾协助美国和欧洲领先的医疗保健公司、技术公司、投资组合公司和咨询公司处理亚太地区的一些最敏感和最具影响力的调查，包括涉及监管调查、合规监督、主动披露和在美国司法部（DOJ）进行谈判的事宜。 饶律师还协助银行、投资基金以及其他金融机构管理与制裁有关的风险。此外，饶律师曾在各类证券集体诉讼、监管机构调查及平行诉讼中，为多家纽约证券交易所上市公司进行辩护。他还针对美国刑事和民事诉讼（包括证券集体诉讼、监管调查以及与电信欺诈、内幕交易、经济间谍和盗取知识产权有关的刑事诉讼）为中国大陆、香港地区和新加坡的个人客户进行辩护。在加入美富前，饶律师曾任职于加州帕洛阿尔托某领先的国际律师事务所，就职期间，他曾代表多家领先技术公司处理内部调查和商业诉讼事宜。饶律师毕业于华盛顿大学圣路易斯分校，以优等成绩获得法律博士学位。在就读法学院期间，他曾担任密苏里州联邦法官的外派实习生，期间曾草拟多份意见书。在就读法学院前，他曾在一家国际知名会计师事务所担任资深并购顾问。饶律师精通英语及普通话。<h4>具有代表性的项目</h4><h5>内部和政府调查 </h5><ul><li>代表一家位于美国的世界领先医药公司处理与其在中国、韩国以及欧洲、中东和非洲地区的运营相关的内部调查和补救项目。</li><li>代表一家位于美国的《财富500强》医疗保健公司处理与其在中国的运营相关的各项内部调查事宜，其中涉及反贿赂、挪用公款、数据隐私和会计欺诈等问题。</li><li>代表一家领先的中国通讯科技公司处理与其在亚洲、南美州和非洲的运营相关的若干FCPA内部调查事宜；曾受聘参与公司与美国司法部之间的和解磋商。</li><li>代表一家位于美国的世界领先专业服务公司处理与其在中国的运营相关的多项内部反贿赂调查事宜。</li><li>代表一家领先的中国机构投资者处理在美国多个州进行的若干商业欺诈调查事宜，以及在特拉华州衡平法法院进行的案值达数十亿美元的平行民事审讯事宜。</li><li>代表一家在纳斯达克证券交易所上市的欧洲医疗保险公司处理针对其在中国的运营实施的六个月合规补救项目。</li><li>代表一家位于加州的世界领先通讯公司处理多项技术出口管制与数据隐私调查事宜，协助响应美国司法部及大陪审团的多项传召出庭令。</li><li>代表一家领先的美国农业公司处理与其中国子公司有关的若干内部调查事宜以及相关商业欺诈问题。</li><li>代表一家欧洲跨国医疗器械生产商处理FCPA内部调查事宜。</li><li>代表一家位于欧洲的在纳斯达克证券交易所上市的医疗器械公司处理与其在中国的运营有关的若干内部调查和反贿赂补救事宜。</li><li>代表一家领先的美国财富管理公司响应美国司法部根据《商品交易法》进行的若干调查事宜。</li><li>代表一家在纽约交易所上市的中国区块链公司处理若干商业欺诈调查及相关证券集体诉讼事宜，并为客户的董事会和高级管理人员提供关于美国证券法的合规事务培训。</li></ul><h5>制裁和出口管制 </h5><ul><li>代表一家美国尖端技术公司处理内部调查，涉及其在中国的运营违反出口规定的指控。</li><li>代表一家大型中国银行的香港子公司处理各种商业制裁事宜，包括涉及美国针对俄罗斯、中国大陆、香港特别行政区、伊朗和朝鲜的制裁制度事宜。</li><li>代表一家总部位于亚洲的大型跨国电信服务提供商处理出口管制和商业制裁事宜。</li><li>代表一家《财富》500强中国银行处理有关其香港的运营的各种美国制裁相关事宜。</li><li>代表一家大型中国银行的香港子公司建立制裁合规计划，包括制裁监测工具。</li><li>代表一家中国领先保险公司的海外投资部门处理美国针对俄罗斯、中国大陆和香港特别行政区的制裁制度下的各种事宜。</li><li>代表一家在中国拥有广泛运营的欧洲大型银行评估制裁和出口管制风险并建立制裁合规计划。</li><li>代表一家领先的中国主权财富基金处理由美国发起并针对俄罗斯和中国的制裁相关事宜。</li></ul><h5>诉讼和仲裁</h5><ul><li>代表美国一家大型线上零售平台处理在美国仲裁协会（AAA）进行的一系列有关劳动、就业和零工经济纠纷的仲裁事宜。</li><li>代表一家中国资产管理公司及其美国子公司处理在旧金山高等法院进行的股东纠纷诉讼。</li><li>代表一家中国大型保险集团公司及其美国子公司处理在美国特拉华州衡平法院审理的一项金额达40亿美元的商业合同纠纷，在特拉华州最高法院进行的上诉，以及同时在加州多个州法院进行的反欺诈调查事宜。</li><li>代表一家在纽约证券交易所上市的中国区块链公司处理在美国新泽西州地区法院进行的证券集体诉讼，以及同时进行的内部调查。</li><li>代表加拿大一家大型运输集团公司处理在美国伊利诺伊州中区地方法院进行的合同纠纷。</li></ul>

Derik’s practice primarily focuses on compliance, regulatory, sanctions, export control, and white-collar matters, as well as investigations under the Foreign Corrupt Practices Act (FCPA) and other anti-bribery laws.He has experience advising multinational companies in finance, healthcare, technology, telecommunications, cryptocurrency, and various other industries. Derik represents corporate clients based in the United States, China, Japan, and Europe in various FCPA and other internal investigations, including in matters relating to commercial bribery, fraud, data privacy, embezzlement, and breach of fiduciary duties. He has extensive experience representing multinational pharmaceutical and medical device companies in conducting sensitive investigations and designing systematic remediation programs. Derik has assisted leading healthcare, technology, investment portfolio, and consulting companies based in the United States and Europe in handling some of the most sensitive and impactful investigations in the APAC region, including matters that involve regulatory investigations, compliance monitorships, self-disclosures, and negotiations before the U.S. Department of Justice (DOJ).Derik also assists banks, investment funds, and other financial institutions in managing sanctions-related risks. Additionally, Derik has advised NYSE-listed companies on their defense in securities class actions, regulatory investigations, and parallel lawsuits. Derik also defends individual clients based in Mainland China, Hong Kong, and Singapore in connection with U.S. criminal and civil lawsuits, including securities class actions, regulatory investigations, and criminal lawsuits involving wire fraud, insider trading, economic espionage, and theft of intellectual property.Prior to joining MoFo, Derik worked at a leading international law firm in Palo Alto, California, where he represented various leading technology companies in internal investigations and commercial litigations. He received his J.D. cum laude from Washington University in St. Louis. While in law school, Derik externed for a federal judge in Missouri and drafted multiple opinions. Before law school, Derik was a senior M&A consultant at a world-leading accounting firm.Derik is fluent in English and Mandarin.<h4>Representative Experience</h4><h5>Internal and Government Investigations</h5><ul><li>A world-leading pharmaceutical company based in the United States in various internal investigations and remediation projects concerning its operations in China, South Korea, and EMEA.</li><li>A Fortune 500 healthcare company based in the United States in various internal investigations concerning its operations in China that involve anti-bribery, embezzlement, data privacy, and accounting fraud issues.</li><li>A leading Chinese communication technology company in certain FCPA internal investigations concerning its operations in Asia, South America, and Africa; engaged in settlement negotiations with DOJ.</li><li>A world-leading professional service firm based in the United States in multiple internal anti-bribery investigations concerning its operations in China.</li><li>A leading Chinese institutional investor in certain business fraud investigations in various states in the United States and a parallel multibillion-dollar civil trial before the Delaware Court of Chancery.</li><li>A Europe-based healthcare company listed on the NASDAQ in a six-month compliance remediation project for its operations in China.</li><li>A world-leading communications company based in California in certain technology export control and data privacy investigations in response to various DOJ and grand jury subpoenas.</li><li>A leading U.S. agricultural company in certain internal investigations concerning its subsidiary in China and related commercial fraud issues.</li><li>A multinational European medical device manufacturer in certain FCPA internal investigations.</li><li>A NASDAQ-listed medical device manufacturer based in Europe in certain internal investigations and anti-bribery remediation matters concerning its operations in China.</li><li>A leading U.S. wealth management company in response to certain DOJ investigations under the Commodity Exchange Act.</li><li>A Chinese blockchain company listed on the New York Stock Exchange in certain commercial fraud investigations and a related securities class action; provided compliance training on U.S. securities laws to the client’s board of directors and senior executives.</li></ul><h5>Sanctions and Export Controls</h5><ul><li>A cutting-edge U.S. technology company in an internal investigation concerning alleged export violations relating to its operations in China.</li><li>A large Chinese bank’s subsidiary in Hong Kong in various commercial sanctions matters, including matters that involve U.S. sanctions regimes relating to Russia, Mainland China, Hong Kong SAR, Iran, and North Korea.</li><li>A large multinational telecommunication service provider headquartered in Asia in export control and commercial sanctions matters.</li><li>A Fortune 500 Chinese bank in various U.S. sanctions-related matters concerning its operations in Hong Kong.</li><li>A large Chinese bank’s subsidiary in Hong Kong in establishing a sanctions compliance program, including sanctions monitoring tools.</li><li>A leading Chinese insurance company’s overseas investment function in handling various matters under the U.S. sanctions regimes relating to Russia, Mainland China, and Hong Kong SAR.</li><li>A large Europe-based bank with extensive operations in China in assessing sanctions and export control risks and establishing a sanctions compliance program.</li><li>A leading Chinese sovereign wealth fund in certain matters concerning U.S.-initiated sanctions against Russia and China.</li></ul><h5>Litigation and Arbitration</h5><ul><li>A major U.S. online retail platform in a series of arbitrations concerning labor/employment and gig economy disputes before the American Arbitration Association (AAA).</li><li>A Chinese asset management firm and its U.S. subsidiaries in certain shareholder dispute lawsuits before the San Francisco Superior Court.</li><li>A major Chinese insurance group company and its U.S. subsidiaries in a US$4 billion contract dispute trial before the Delaware Court of Chancery, the appeal before the Delaware Supreme Court, and parallel anti-fraud investigation matters before various California state courts.</li><li>A Chinese block chain company listed on the New York Stock Exchange in a securities class action before the United States District Court for the District of New Jersey, and a parallel internal investigation.</li><li>A major Canadian transportation group company in a contract dispute before the United States District Court for the Central District of Illinois.</li></ul>

Derik Rao

Xiaoxi Lin has over 15 years’ experience advising private equity and investment fund clients on their most complex and strategic transactions, including control and leveraged buyouts, growth capital investments and public takeovers.Xiaoxi is one of the most experienced practitioners in Asia in U.S. public transactions, including take privates, PIPE (private investment in public equity) and SPAC/de-SPAC transactions.He has significant experience advising both financial sponsors and corporations on M&A transactions, with a particular focus on the technology, consumer, healthcare and energy sectors, as well as inbound and outbound investments related to China and the U.S.Xiaoxi has advised a wide range of financial sponsors across the U.S. and Asia, including Advantage Partners, Bain, Baring Private Equity Asia (now EQT Private Capital Asia), Boyu Capital, Carlyle, Centurium Capital, China Everbright, CITIC Capital/Trustar Capital, C Capital, CPE, Canada Pension Plan Investment Board (CPPIB), DCP, Evenstar Capital, Genesis Capital, GF Capital, GP Investments, Hammer Capital, Hillhouse, KKR, Malaysia’s sovereign wealth fund, Mubadala, Ocean Link, Orchid Asia, PAG, Snow Lake, Thomas H. Lee Partners, TPG and Warburg Pincus.Xiaoxi studied automation at Tsinghua University in Beijing, and actuarial science at the University of Hong Kong. He holds a Juris Doctor from Georgetown University Law Center. He has also passed all three levels of the chartered financial analyst (CFA) exam. From 2017 to 2021, Xiaoxi was the principal author of the China chapter in The Private Equity Review, an annual publication by Lexology In-Depth (formerly The Law Reviews).Xiaoxi is fluent in English, Mandarin, Cantonese and Shanghainese.<h4>Representative Experience</h4><ul><li>CPE, a Chinese alternative investment firm, in connection with its US$350 million joint venture with Restaurant Brands International (RBI), one of the world's largest multinational fast food holding company, to operate Burger King in China which has around 1,250 restaurants in total. This transaction is one of the most significant private equity-led transactions in China’s consumer sector in 2025.</li></ul><ul><li>The Carlyle Group, China International Trust Investment Corporation (CITIC) Limited and CITIC Capital Holdings in the US$2.08 billion acquisition of McDonald’s operations in mainland China and Hong Kong SAR and negotiation of a 20-year master franchise agreement, the largest McDonald’s franchise in the world.</li><li>An investor consortium, comprising Warburg Pincus Asia, General Atlantic Singapore Fund Pte., Ocean Link Partners, and Jinbo Yao, Chairman of the Board and Chief Executive Officer of 58.com, in the take-private of 58.com Inc., China’s largest online classifieds marketplace, at a valuation of approximately US$8.7 billion. This is the second-largest U.S. take-private in Asia to date.</li><li>The Special Committee of Qihoo 360 (NYSE: QIHU) in its US$9.3 billion going private transaction. This is the largest U.S. take-private in Asia to date.</li><li>The Special Committee of Nord Anglia (NYSE: NORD) in its US$4.3 billion going private transaction.</li><li>Plus, a provider of self-driving truck technology, in its proposed US$2.5 billion de-SPAC transaction and the related US$180 million PIPE financing from U.S. and Asian institutional investors.</li><li>BaiJiaYun in its reverse merger with NASDAQ-listed Fuwei Films (NASDAQ: FFHL).</li><li>Hillhouse, in various public and private investments in Asia and globally.</li><li>PAG in its US$200 million investment in Flash, a leading Southeast Asia logistics platform.</li><li>Sea Limited, a leading global consumer internet company, in the acquisition by its digital entertainment arm, Garena, of Phoenix Labs, an acclaimed independent games development company founded in Vancouver.</li><li>Consortium of Bain Capital and GIC in their acquisition of a minority interest in QuEST, a global engineering solutions provider.</li></ul>

林晓希律师在代表私募股权和投资基金客户处理其最复杂、最具战略性的交易方面拥有超过15年的丰富经验，其中包括控制权和杠杆收购、成长资本投资和上市公司并购。林律师是亚洲地区处理美国上市公司交易方面经验最丰富的律师之一，尤其擅长处理私有化交易、PIPE（私人投资公开股权）和SPAC/de-SPAC交易。林律师在代表金融投资者和企业处理并购交易方面拥有丰富的经验，尤其侧重于科技、消费、医疗保健和能源行业，以及与中国和美国相关的境内外投资。林律师曾代表美国和亚洲的多家金融投资者，包括Advantage Partners、贝恩资本、霸菱亚洲投资基金（现为殷拓亚洲私人资本）、博裕资本、凯雷、大钲资本、中国光大、中信资本/信宸资本、C资本、CPE源峰、加拿大养老金计划投资委员会（CPPIB）、德弘资本、Evenstar Capital、元生资本、广发资本、GP Investments、黑马资本、高瓴投资、KKR、马来西亚主权财富基金、穆巴达拉、鸥翎投资、兰馨亚洲、太盟投资集团、雪湖资本、THL基金、TPG和华平投资。林律师曾就读于北京清华大学自动化专业，毕业于香港大学精算专业，并拥有美国乔治城大学法学院的法律博士学位。他还通过了特许金融分析师（CFA）所有三个级别的考试。从2017年至2021年，林律师是《私募股权评论》中国章节的主要作者，该书是由Lexology In-Depth（原The Law Reviews）出版的年度刊物。林律师的英语、普通话、粤语和上海话均十分流利。<h4>具有代表性的交易</h4><ul><li>代表中国另类投资公司CPE源峰就其与世界上最大的餐饮公司之一餐饮品牌国际集团（Restaurant Brands International，简称 RBI）成立价值3.5亿美元的合资企业。该合资企业将负责汉堡王在中国的运营，目前在全国拥有约 1,250 家餐厅。本次交易是 2025 年中国消费行业中由私募股权基金主导的最具代表性交易之一。</li></ul><ul><li>代表凯雷集团、中国国际信托投资公司和中信资本控股有限公司处理以20.8亿美元收购麦当劳在中国大陆和香港特别行政区的运营事宜，并就有关麦当劳全球最大特许经营权的20年期限《主特许经营协议》进行谈判。</li><li>代表由华平亚洲、General Atlantic Singapore Fund Pte.、鸥翎投资和58同城董事长兼首席执行官姚劲波组成的投资者财团处理以约87亿美元的估值对58同城进行私有化事宜。58同城是中国最大的在线分类信息网站。此次交易是迄今为止亚洲第二大美国私有化交易。</li><li>代表奇虎360（纽约证券交易所股票代码：QIHU）的特别委员会处理其93亿美元的私有化交易。此次交易是迄今为止亚洲最大的美国私有化交易。</li><li>代表诺德安达（纽约证券交易所股票代码：NORD）的特别委员会处理其43亿美元的私有化交易。</li><li>代表Plus处理其拟议进行的25亿美元de-SPAC交易，以及从美国和亚洲机构投资者获得1.8亿美元PIPE融资的事宜。Plus是一家自动驾驶卡车技术提供商。</li><li>代表百家云处理其与在纳斯达克证券交易所上市的富维薄膜公司（纳斯达克证券交易所股票代码：FFHL）进行的反向合并事宜。</li><li>代表高瓴投资处理其在亚洲和全球进行的各种公开和私人投资事宜。</li><li>代表太盟投资集团向Flash进行2亿美元投资的事宜。Flash是一家领先的东南亚物流平台。</li><li>代表冬海集团处理其数字娱乐公司Garena收购Phoenix Labs的事宜。冬海集团是一家领先的全球消费互联网公司。Phoenix Labs是一家总部位于温哥华的知名独立游戏开发公司。</li><li>代表贝恩资本和新加坡政府投资公司组成的财团处理收购全球工程解决方案提供商QuEST少数股权的事宜。</li></ul>

Xiaoxi Lin

Tingting is a member of Morrison Foerster’s preeminent Data, Cyber + Privacy practice and she advises on a diverse range of privacy, data protection, and cybersecurity compliance issues relevant to China across a wide spectrum of industries. Tingting has a deep understanding of, and extensive experience advising on, China’s fast evolving data regulatory regime.Tingting also helps clients with other regulatory compliance advisory matters, including TMT, AI, as well as labor and employment.Prior to joining Morrison Foerster, Tingting worked as an associate in a China joint operations office of a leading international law firm.Tingting is fluent in Mandarin and English.Tingting is designated as a Certified Information Privacy Professional (CIPP/Europe) by the International Association of Privacy Professionals (IAPP).<h4>Representative Experience</h4><ul><li>A multinational advanced-technology conglomerate corporation in regulatory and data protection compliance in China, including significant assistance to the client in successfully passing a provincial CAC’s review of its consolidated data export application that covers dozens of affiliates in China.</li></ul><ul><li>A multinational financial services corporation and bank card clearing brand in significant China and APAC regional data protection compliance strategies as well as general corporate matters.</li><li>A multinational auto brand as well as its financial leasing business segment in an extensive China data protection compliance review of country operations and data governance and strategies.</li></ul><ul><li>A leading global professional services company in an in-depth review of compliance with China’s revised national security and data security regimes and formation of compliance strategies.</li><li>A membership-based warehouse store in regulatory and data protection compliance in China, including significant assistance to the client in its consolidated data export application that covers all subsidiaries in China.</li><li>A multinational financial services corporation in regulatory and data protection compliance in China, including significant assistance to the client in its data export applications.</li><li>A foreign-invested telematics business in regulatory and data protection compliance in China, including significant assistance to the client in reaching agreements with auto brands on the treatment of vehicle data after expiry of telematics services.</li></ul>

高律师是美富久负盛名的隐私与数据安全（Data, Cyber + Privacy）业务组的成员。她协助客户处理与中国相关的隐私、数据保护以及网络安全合规等各类法律事宜，涉及的行业领域非常广泛。高律师对中国快速发展的数据监管制度有着深刻的理解，并在此方面拥有极为丰富的执业经验。高律师亦协助客户处理各类其他合规监管及咨询事宜，包括技术、媒体和电信（TMT）、人工智能以及劳动与雇佣。在加入美富之前，高律师曾是一家领先国际律所的中国联营办公室的律师。高律师精通普通话与英语。高律师是IAPP（International Association of Privacy Professionals）认证的欧盟信息隐私专家（Certified Information Privacy Professional/Europe）。<h4>具有代表性的项目 </h4><ul><li>代表一家跨国高科技企业集团处理其中国监管和数据保护事宜，包括协助客户顺利通过省级网信部门对其涵盖数十家在华关联公司在内的数据出境申请的审查。</li><li>代表一家跨国金融服务公司和银行卡清算品牌处理中国和亚太地区重要的区域性数据保护合规策略以及一般公司事宜。</li><li>代表一家跨国汽车品牌及其融资租赁业务部处理针对中国运营所进行的广泛的中国数据保护合规审查以及就数据治理和策略提供法律意见。</li><li>代表一家全球领先的专业服务公司深入评估其对中国新近修订的国家安全与数据安全相关法律的遵守情况，并提出合规策略。</li><li>代表一家会员制仓储量贩卖场处理其中国合规和数据保护事宜，包括为涵盖客户全部在华子公司在内的数据出境申请提供协助。</li><li>代表一家跨国金融服务公司处理其中国合规和数据保护事宜，包括协助其数据出境申请。</li><li>代表一家外资车联网公司处理其中国合规和数据保护事宜，包括协助客户与车企就车联网服务到期后的汽车数据处理事宜达成协议。</li></ul>

Tingting Gao

Associate

Sarah frequently advises clients in strategic corporate-commercial and technology transactions in the sectors of life science and TMT, including in-licensing, out-licensing, collaboration, and development agreements in various types of traditional and emerging technology offerings, including software-as-a-service, on-premises software, and technology services and maintenance, and in a broad range of pharmaceutical products and technologies, including biopharmaceutical drugs, immunotherapies, antibody therapeutics, and vaccines.Before joining MoFo, Sarah was an associate in the Shanghai office of an international law firm. She is fluent in English and Mandarin.<h4>Representative Experience</h4><ul><li>A leading healthcare investment firm’s portfolio company in its series of license-in and license-out deals concerning: (i) the development and option agreement and license agreement with a private biotechnological company in the North America for the development of lipid nanoparticles (LNP) formulations for delivery of mRNA and for the commercialization and manufacturing of the protein product and the vaccine product utilizing the LNP technology; and (ii) the licensing-out agreement with a Hong Kong listed company for the development and commercialization of the mRNA technology in Greater China.</li></ul><ul><li>Hangzhou DAC Biotechnology Co., Ltd. on its collaboration and license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, for the development and commercialization of antibody drug conjugate (ADC) products.</li><li>Jiangsu Hengrui Medicine Co., Ltd. in its US$165 million exclusive license agreement with Novaliq GmbH, a German pharmaceutical company focusing on ocular therapeutics, to develop, manufacture and commercialize the innovative, water-free drugs NOV03 (perfluorohexyloctane) and CyclASol® for the treatment of dry eye disease in mainland China, Hong Kong, Macau and Taiwan.</li><li>A FinTech firm in the strategic partnership between a pan-Asia retailer and a Hong Kong bank to construct a new customer loyalty and reward program to replace the current co-branded credit card program on the market.</li><li>An automobile retailer that is a subsidiary of a multi-national dealership operator in its ERP software license and support agreement and the service agreement with a European multi-national software corporation, on the subscription of its core software products and technologies.</li></ul>

王家尧律师经常就生命科学以及科技、媒体和电信（TMT）领域战略性的公司商业交易和技术交易向客户提供咨询，包括协助客户编制被许可协议、对外许可协议、协作协议及开发协议，涉及各种传统及新兴技术产品和服务，包括软件即服务（SaaS）、本地部署软件以及技术服务和维护等，还涉及广泛的医药产品和技术，包括生物制药产品、免疫疗法、抗体疗法和疫苗等。在加入美富前，王律师是一家国际律所上海办事处的律师。她精通英语和普通话。<h4>具有代表性的项目 </h4><ul><li>代表某顶级医疗保健投资机构的被投资公司处理涉及下列事宜的系列被许可及对外许可交易：（1）代表某领先的生物医药公司就其与加拿大某生物公司签订开发和选择权协议以及对内许可协议提供法律服务，以开发用于传递mRNA的脂质纳米颗粒（LNP）配方，并对利用LNP技术的蛋白质产品和疫苗产品进行商业化和生产；以及（2）与某香港上市公司签订对外许可协议，以在大中华区对mRNA技术进行开发和商业化。</li></ul><ul><li>代表杭州多禧生物科技有限公司与强生公司旗下杨森制药生物科技公司达成合作和许可协议，用于抗体偶联药物（ADC药物）的开发与商业化。</li></ul><ul><li> 代表江苏恒瑞医药股份有限公司处理其与Novaliq GmbH（一家专注于眼部治疗的德国制药公司）的1.65亿美元独家许可协议，对创新型无水药物NOV03（全氟己内酯）和CyclASol®进行开发、生产和商业化，用于在中国大陆、香港、澳门和台湾地区治疗干眼症。</li></ul><ul><li> 代表一家金融科技公司处理其所属的泛亚洲零售商与一家香港银行的策略性合伙，订立新的老顾客奖励计划来取代目前市场上的联合品牌信用卡计划。</li></ul><ul><li> 代表一家国际汽车经销集团旗下的汽车零售商，处理其ERP软件许可证和支持协议及与一家欧洲国际软件公司的服务协议，以订阅模式付费使用其核心软件产品和技术。</li></ul>

Sarah Wang

Gigi’s practice focuses on technology transactions, data privacy, and regulatory compliance advisory work across various industries. She has significant experience with private cross-border M&A and private equity investments. Gigi also has extensive knowledge of cross-border commercial technology transactions. She has worked with clients on a variety of projects from traditional technology transfer arrangements to complex collaborative development relationships. She has provided specialist operational technology law advice to clients in Greater China and Asia.Gigi handles all types of data advisory work across Greater China. She regularly advises clients on cutting-edge technology and IP regulatory matters covering data privacy, data security, data localization, cross-border data transfer, cybersecurity, and fintech.Prior to joining Morrison Foerster, Gigi was an associate in the Hong Kong office of a major international law firm.Gigi is fluent in English, Cantonese, and Mandarin.<h4>Representative Experience:</h4><ul><li>An NYSE-listed U.S. video game engine company in connection with<ul><li>Establishment and operation through a leading Chinese online partner of PRC-based cloud services for development studio customers in China; and</li><li>Establishment of a joint venture with multiple Tier 1 Chinese Internet technology companies to create, develop, and roll out a China-specific platform and ecosystem based on the client’s industry-leading products, technologies, and online services.</li></ul></li><li>A U.S. multinational consumer technology company with respect to its international payment network, including advising on regulatory requirements in Hong Kong and Macau, and issues pertaining to stored value card use of NFT wallets in metro transport systems.</li><li>The venture arm of an international payment network with respect to strategic investments in<ul><li>Early stage fintech companies, including a B2B and B2C SaaS platform for tax processing and payment in Singapore; </li><li>An open finance tech platform providing solutions for financial institutions in Southeast Asia (SEA); and</li><li>An Indonesian B2C travel services platform operating throughout SEA.</li></ul></li><li>A leading Chinese Internet services company in multiple debt and equity financings of a securities fintech business licensed by the SFC and which offers a Chinese language app for trading equities in select international markets.</li><li>A number of multinationals in various industries including technology, consumer health, and hospitality on data privacy and regulatory issues.</li></ul>

袁律师的业务重点为多个行业的技术交易、数据隐私及合规工作。她在处理非上市公司跨境并购和私募股权投资方面亦拥有丰富经验。袁律师还深谙跨境商业性技术交易。她曾协助客户处理过各种项目，从传统的技术转让安排到复杂的协同开发关系，并曾向大中华区和亚洲的客户提供专业的运营技术法律服务。袁律师在大中华区各地处理各种数据咨询工作。她经常就涵盖数据隐私、数据安全、数据本地化、跨境数据传输、网络安全和金融科技等的前沿技术和知识产权监管事宜向客户提供法律服务。<h4>具有代表性的项目：</h4><ul><li>代表某在纽交所上市的美国视频游戏引擎公司<ul><li>处理其通过中国领先的在线合作伙伴，为在中国开拓工作室客户设立和运营基于中国的云服务相关事宜。</li><li> 处理其与多家中国一级的科技互联网公司成立合资企业的事宜，以客户行业领先的产品、技术和在线服务为基础，创建、开发和推出中国特有的平台和生态系统。</li></ul></li><li> 代表一家美国跨国消费技术公司处理其国际支付网络的相关事宜，包括就香港和澳门的监管要求以及在储值卡、地铁运输系统中使用 NFT 钱包有关的问题提供法律服务。</li><li> 代表某国际支付网络的风险投资部门处理其对一系列公司和平台进行的战略投资：<ul><li>某早期金融技术公司，包括应用于新加坡税务处理和缴费业务的B2B和B2C软件服务平台；</li><li>某开放式金融技术平台，为东南亚地区的金融机构提供解决方案；</li><li>在整个东南亚开展业务运营的印度尼西亚某B2C旅游服务平台。</li></ul></li><li>代表一家中国领先互联网服务公司处理对一家在香港和深圳的证券金融技术企业的多次债务及股权融资。这家证券金融技术企业提供用于在所选国际市场上交易股权的中文应用程序。</li><li>为科技、消费者健康、酒店等各种行业的数家跨国公司提供数据隐私和监管问题方面的法律建议。</li></ul>